News
Hydroxychloroquine ineffective for COVID-19, VA study suggests
April 23, 2020
The retrospective study, which included data from 368 men hospitalized with confirmed COVID-19 and treated in VA medical centers, showed an association between HCQ and higher mortality.
News
Signature STEMI sign may be less diagnostic in the COVID-19 age
April 22, 2020
ST-segment elevation, often a ticket to the cath lab, may not indicate STEMI as reliably as before hospitals started to fill with COVID-19 patients, who may have other ST-segment–elevating conditions.
News
ACEI/ARBs linked with survival in hypertensive, Chinese COVID-19 patients
April 22, 2020
A study drawing from 1,128 hypertensive, Chinese patients with COVID-19 suggested that those on an ACEI or ARB had better 28-day survival.
News
Mislabeled clopidogrel lot recalled, may contain simvastatin
April 21, 2020
International Laboratories has recalled one lot of clopidogrel tablets packaged in bottles of 30 tablets because it may contain simvastatin instead of clopidogrel.
News
ASE issues echocardiography guidance amid COVID-19 pandemic
April 21, 2020
The ASE urges careful consideration of whom, where, and how to image to reduce the risks of SARS-CoV-2 transmission among echocardiography providers.
News
PCSK9 inhibitors unexpectedly link with lower VTE, aortic stenosis
April 21, 2020
Post hoc analyses of data from as many as 46,000 patients showed surprising links between PCSK9 inhibition and reduced rates of VTE and aortic stenosis.
News
Interim guidance for CPR in patients with COVID-19
April 20, 2020
Performing CPR on patients with COVID-19 raises unique challenges. Interim guidance suggests approaches to mitigate risk to patients and providers.
News
COVID-19: How intensive care cardiology can inform the response
April 17, 2020
Cardiologists recommend adaptive staffing, organizational structure, medical treatment, and regional care pathways in the context of COVID-19.
News
HFpEF: Gender difference in sacubitril/valsartan response remains mystery
April 17, 2020
Why did women on sacubitril/valsartan get a 27% reduction in cardiovascular death and heart failure hospitalization, while the men got nothing?
News
Protean manifestations of COVID-19: “Our ignorance is profound”
April 17, 2020
“Make sure they didn’t die in vain.”